NCT03733561View on ClinicalTrials.gov

A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

November 9, 2018

Primary Completion Date

December 23, 2018

Study Completion Date

December 23, 2018

Conditions
Parkinson Disease
Interventions
DRUG

LY03003

LY03003 (rotigotine extended release microspheres for intramuscular \[IM\] injection)

DRUG

Neupro 4Mg/24Hr Transdermal Patch

neupro patch

Trial Locations (1)

21201

Pharmaron CPC, Inc., Baltimore

All Listed Sponsors
lead

Luye Pharma Group Ltd.

INDUSTRY

NCT03733561 - A Study to Assess Pharmacokinetic Profiles of LY03003 and Neupro | Biotech Hunter | Biotech Hunter